Earl F. Kimble

614 total citations
19 papers, 411 citations indexed

About

Earl F. Kimble is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Earl F. Kimble has authored 19 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Earl F. Kimble's work include Inflammatory mediators and NSAID effects (6 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Estrogen and related hormone effects (3 papers). Earl F. Kimble is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Estrogen and related hormone effects (3 papers). Earl F. Kimble collaborates with scholars based in Switzerland, United States and France. Earl F. Kimble's co-authors include Edmond C. Ku, Ronald E. Esser, Himanshu V. Kothari, Paul Marshall, Janet Dawson, Timothy J. Kowalski, Roger A. Fujimoto, Yoshitaka Satoh, Elizabeth Quadros and Warren Lee and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Earl F. Kimble

19 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Earl F. Kimble Switzerland	10	197	105	79	58	51	19	411
Margaret E. McCann United States	14	122 0.6×	61 0.6×	236 3.0×	23 0.4×	65 1.3×	19	550
A. Blackham United Kingdom	11	149 0.8×	35 0.3×	69 0.9×	60 1.0×	31 0.6×	24	346
Jacqueline Bonnet France	11	75 0.4×	150 1.4×	178 2.3×	65 1.1×	79 1.5×	13	531
Richard C. Witt United States	8	185 0.9×	35 0.3×	221 2.8×	65 1.1×	48 0.9×	16	506
C. S. McFarlane Canada	14	135 0.7×	98 0.9×	199 2.5×	71 1.2×	288 5.6×	20	619
Ray Stepney United Kingdom	6	173 0.9×	79 0.8×	114 1.4×	127 2.2×	140 2.7×	8	490
Fujio Asanuma Japan	12	168 0.9×	121 1.2×	123 1.6×	59 1.0×	210 4.1×	20	472
Tetsuro Hiratsuka Japan	15	185 0.9×	16 0.2×	90 1.1×	59 1.0×	44 0.9×	26	474
S Yamamoto United Kingdom	9	102 0.5×	17 0.2×	79 1.0×	120 2.1×	43 0.8×	18	351
Ninder Panesar United States	13	129 0.7×	25 0.2×	167 2.1×	85 1.5×	29 0.6×	23	469

Countries citing papers authored by Earl F. Kimble

Since Specialization

Citations

This map shows the geographic impact of Earl F. Kimble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl F. Kimble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl F. Kimble more than expected).

Fields of papers citing papers by Earl F. Kimble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Earl F. Kimble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl F. Kimble. The network helps show where Earl F. Kimble may publish in the future.

Co-authorship network of co-authors of Earl F. Kimble

This figure shows the co-authorship network connecting the top 25 collaborators of Earl F. Kimble. A scholar is included among the top collaborators of Earl F. Kimble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Earl F. Kimble. Earl F. Kimble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

McGuinness, Brian, Andrew G. Cole, Ian Henderson, et al.. (2010). Discovery of 2-aminoimidazopyridine adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(22). 6845–6849. 9 indexed citations

Merritt, J. Robert, Vidyadhar M. Paradkar, Ruiyan Liu, et al.. (2010). Novel pyrrolidine heterocycles as CCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(18). 5477–5479. 8 indexed citations

King, Jonathan N., Janet Dawson, Ronald E. Esser, et al.. (2009). Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2. Journal of Veterinary Pharmacology and Therapeutics. 32(1). 1–17. 55 indexed citations

Merritt, J. Robert, Jinqi Liu, Elizabeth Quadros, et al.. (2009). Novel Pyrrolidine Ureas as C−C Chemokine Receptor 1 (CCR1) Antagonists. Journal of Medicinal Chemistry. 52(5). 1295–1301. 18 indexed citations

Lin, Tsung H., Axel Metzger, David Diller, et al.. (2006). Discovery and Characterization of Triaminotriazine Aniline Amides as Highly Selective p38 Kinase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 318(2). 495–502. 9 indexed citations

Esser, Ronald E., Carol Berry, Zhengming Du, et al.. (2005). Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2. British Journal of Pharmacology. 144(4). 538–550. 100 indexed citations

Pellas, Theodore C., William C. Boyar, Jan van Oostrum, et al.. (1998). Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo. The Journal of Immunology. 160(11). 5616–5621. 42 indexed citations

Chovan, James P., et al.. (1997). Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(4). 470–474. 7 indexed citations

Satoh, Yoshitaka, et al.. (1995). Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4-benzodioxan as Orally Active 5-Lipoxygenase Inhibitors. Journal of Medicinal Chemistry. 38(1). 68–75. 29 indexed citations

10.

Kimble, Earl F., et al.. (1995). The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor. Inflammation Research. 44(S2). S181–S182. 3 indexed citations

11.

Kimble, Earl F., Timothy J. Kowalski, Philip J. Peters, et al.. (1995). CGS 26529: The biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action. Inflammation Research. 44(S2). S147–S148. 1 indexed citations

12.

Satoh, Yoshitaka, et al.. (1994). Benzoxepin and benzothiepin derivatives as potent, orally active inhibitors of 5-lipoxygenase. Bioorganic & Medicinal Chemistry Letters. 4(4). 549–552. 5 indexed citations

13.

Satoh, Yoshitaka, James L. Stanton, Alan Hutchison, et al.. (1993). Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors. Journal of Medicinal Chemistry. 36(23). 3580–3594. 29 indexed citations

14.

Kimble, Earl F., et al.. (1991). CGS 22745: A selective orally active inhibitor of 5-lipoxygenase. Inflammation Research. 34(1-2). 125–128. 4 indexed citations

15.

Kimble, Earl F., et al.. (1991). Leukotriene biosynthesis inhibition by aryl and aroyl substituted naphthoquinones. Inflammation Research. 34(1-2). 145–147. 1 indexed citations

16.

Ku, Edmond C., et al.. (1988). Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 959(3). 332–342. 21 indexed citations

17.

Cohen, David S., et al.. (1987). CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben. European Journal of Pharmacology. 133(3). 265–273. 6 indexed citations

18.

Ku, Edmond C., et al.. (1985). The effects of diclofenac sodium on arachidonic acid metabolism. Seminars in Arthritis and Rheumatism. 15(2). 36–41. 49 indexed citations

19.

Ku, Edmond C., et al.. (1985). Effects of Diclofenac Sodium on Arachidonic Acid Metabolism. Birkhäuser Basel eBooks. 17. 189–193. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact